Track market-moving stories before they get noisy

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

© Andrey Gorgots / Shutterstock.com

Strive (NASDAQ:ASST) stock is up 13% in Friday afternoon trading while Bitmine Immersion Technologies (NYSE:BMNR | BMNR Price Prediction) shares are up 5%, as a broad crypto rally sends both names sharply higher. The catalyst is clear: Bitcoin (CRYPTO:BTC) is up 5% over the past 24 hours, trading near $77,800, while Ethereum (CRYPTO:ETH) has surged 5.5% to $2,444.

Both companies function as crypto proxy equities, meaning their stock prices move in close correlation with the digital assets they hold on their balance sheets. On days when Bitcoin and Ethereum surge, names like ASST and BMNR tend to amplify those moves, giving equity investors leveraged-style exposure without touching a crypto wallet.

The crypto rally itself is a recovery within a broader 2026 pullback. Bitcoin remains down 11% year-to-date, and Ethereum is down 17% year-to-date. Today’s move looks more like a tactical bounce than a trend reversal, but it’s clearly enough to light up the crypto proxy trade.

Strive’s Bitcoin Treasury Fuels the Bigger Move Strive’s outsized 12% gain reflects just how directly its fortunes are tied to Bitcoin’s price. The company holds 13,628 BTC as of March 17, making its net asset value highly sensitive to any meaningful move in Bitcoin. When BTC jumps 5% in a single session, the equity tends to react with even greater velocity.

The company’s recent financial momentum adds to the bullish backdrop. Strive reported a Q4 2025 Bitcoin Yield of 22%, with a Bitcoin Gain of 1,305 BTC worth $114.3 million. Into Q1 2026, it had already posted a quarter-to-date Bitcoin Yield of 14% and a Bitcoin Gain of 1,050 BTC worth $78.2 million.

Wall Street is taking notice. TD Cowen initiated coverage of Strive with a Buy rating and a $26 price target on April 10, citing the company’s positioning as the first publicly traded Bitcoin treasury asset management firm. That analyst consensus, with a consensus target price of $20.33, suggests meaningful upside from recent trading levels even before today’s move.

Strive is also pursuing a pending acquisition of Semler Scientific, which would add 5,048 BTC to its treasury. CEO Matthew Cole has described a multi-trillion dollar digital credit opportunity, anchored by the company’s SATA perpetual preferred structure. That growth narrative, layered on top of a rising Bitcoin price, is what’s driving ASST stock to its highest levels in recent weeks.

Bitmine Rides the Ethereum Wave Bitmine Immersion Technologies stock’s 5% gain today is a direct function of Ethereum’s move. The company claims the largest ETH treasury in the world, holding over 3.73 million ETH valued near $10 billion. With Ethereum up sharply on the day, Bitmine’s balance sheet is appreciating in real time.

The company’s long-term ambition is to acquire 5% of all ETH, an audacious target that would make it one of the most concentrated single-asset treasury plays in the public markets. Bitmine’s MAVAN (Made-in-America Validator Network) infrastructure supports ETH staking, giving Bitmine an operational income stream alongside its treasury position.

Retail options traders have been active around BMNR. A post on r/options titled “funding my monthly expenses selling covered calls on BMNR” drew 75 upvotes and 17 comments on April 10, reflecting how traders are positioning around the stock’s volatility. That kind of retail engagement tends to amplify moves on high-volume crypto days like today.

Wall Street analysts carry a consensus Buy rating on BMNR stock, with a price target of $36. The stock’s 52-week low of $3.199 and 52-week high of $160.95 illustrate just how wide the range of outcomes can be for a name this tightly coupled to a single volatile asset.

What to Watch For ASST stock, watch for whether today’s gains hold above $15.50. Any continuation in Bitcoin above the $78,000 level could sustain the momentum into the close.

For BMNR stock, the key question is whether Ethereum can hold its gains through the afternoon session. If ETH fades, expect BMNR to give back a portion of today’s move quickly. Both stocks remain volatile proxies, and today’s session is a reminder that the crypto proxy trade cuts both ways.

Markets are once again hopeful as tensions in the Middle East ease, and stocks have staged a furious rally to new all-time highs over the last few weeks. But despite the renewed risk-on sentiment, cryptocurrencies have been oddly quiet, and most remain well below the August 2025 peak. However, Bitcoin recently reclaimed the key $75,000 price level, which is significant for investors. And if you’re looking to add crypto exposure to your portfolio, there’s a pair of small-cap Digital Asset Treasury (DAT) stocks that could pique your interest.

Get Twenty One Capital alerts:

Why $75,000 Was a Key Level for Bitcoin InvestorsA move above $75,000 for Bitcoin has been long-awaited by the market, and for several reasons. First, this has been a resistance level since the price collapsed in early February, and when key resistance levels are breached, they often turn into new areas of support. The crucial 100-day moving average is right around this price, and setting a new BTC floor at $75,000 would restore some confidence in the market.

Not only is $75,000 a psychological sticking point, but it's also a crucial level for Bitcoin market makers. According to options data, market makers have negative gamma around $75,000, which indicates how quickly the price of derivatives responds to changes in the underlying asset's price. A negative gamma situation means market makers act in reverse of their typical behavior, which is buying dips and selling rallies to hedge and provide liquidity. When market makers have negative gamma, they often must sell dips and buy rallies to hedge, which is like putting price movement on steroids.

Now that Bitcoin has broken through $75,000 and risk-on behavior has returned to most market sectors, crypto stocks are becoming attractive once again, and many of these companies are still trading well below their previous all-time highs.

If you’re looking to add crypto exposure through a typical brokerage account, the following two stocks both have unique business models and technical tailwinds suggesting upward momentum is beginning to build.

Twenty One Capital: High Risk, High Reward Bitcoin TreasuryThe typical DAT model uses a metric called multiple on Net Asset Value (mNAV) to decide when to buy and sell its assets. A stock with an mNAV of 1.0 trades at neither a discount nor a premium to its Bitcoin holdings, but an mNAV above 1.0 means investors are paying more than $1 for every $1 of Bitcoin exposure. On the other hand, an mNAV below 1.0 means the stock trades at a discount to its holdings, which is usually a bad sign for the company. A treasury company that the market trusts, like Strategy Inc. NASDAQ: MSTR, typically trades with an mNAV of 2.5-3.0 because investors are willing to pay a premium for exposure to Michael Saylor’s management. And when Strategy raises capital to buy more Bitcoin, this increases the Bitcoin-per-share value for existing shareholders.

Twenty One Capital TodayXXI

Twenty One Capital

$5.42 +0.09 (+1.59%)

As of 10:10 AM Eastern

This is a fair market value price provided by Massive. Learn more.

52-Week Range$5.31▼

$12.51 Twenty One Capital Inc. NYSE: XXI currently trades at a diluted mNAV of 0.79, meaning investors are paying only 79 cents for every $1 of Bitcoin exposure. The downside to an mNAV under 1.0 is that the company can’t issue new shares to fund Bitcoin purchases without excessively diluting existing shareholders. However, Twenty One Capital is now the third-largest public Bitcoin holder, and this discount could narrow if cryptocurrencies continue to rally.

XXI shares are finally starting to get some technical tailwinds, too. A bullish crossover on the Moving Average Convergence Divergence (MACD) helped propel the stock back over its 50-day moving average, and the crucial 100-day moving average is now in sight. XXI shares have been below their 100-day moving average since last August, so a move above that level could bring renewed pressure to accumulate before the mNAV discount closes.

Strive Inc: A New Strategy on the Digital Asset Treasury ModelStrive Inc. NASDAQ: ASST is taking a different approach to the traditional DAT model. Instead of issuing new common shares to buy digital assets, Strive uses a preferred stock vehicle to fund its purchases. SATA is the company’s Variable Rate Series A Perpetual Preferred Stock, and using preferred stock to fund Bitcoin accumulation means Strive can keep buying BTC without diluting common stockholders, even when ASST trades at an mNAV of 1.0 or below.

Strive Today

$14.34 -0.09 (-0.62%)

As of 10:11 AM Eastern

This is a fair market value price provided by Massive. Learn more.

52-Week Range$7.02▼

$252.00Price Target$28.00

SATA shares pay a 13% annual dividend, so if Bitcoin compounds at more than 13% annually, Strive can arbitrage the spread between its Bitcoin holdings and dividend obligations. The preferred stock has no maturity date, meaning there’s no principal to return, and the proceeds can be used directly for new BTC purchases.

Investors should be aware that using preferred stock to fund digital asset purchases for the benefit of common shareholders is an unprecedented maneuver, and ASST shares carry unique risks (i.e., if Bitcoin gains fail to match the dividend yield). But if this model holds, ASST shares could look like a tremendous bargain, and there’s evidence of an uptrend beginning. The stock posted a six-day winning streak in mid-April, and the share price is now back above the 50-day and 100-day moving averages. The Relative Strength Index (RSI) has confirmed the upward momentum, which should continue growing as long as Bitcoin keeps rallying.

Should You Invest $1,000 in Twenty One Capital Right Now?Before you consider Twenty One Capital, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Twenty One Capital wasn't on the list.

While Twenty One Capital currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

DALLAS, April 27, 2026 (GLOBE NEWSWIRE) -- Strive, Inc. (Nasdaq: ASST; SATA) (“Strive” or the “Company”) today announced the purchase of an additional ~789 Bitcoin, bringing its total holdings to ~14,557 Bitcoin. Additionally, Strive announced that True North, a research & media sub-brand of Strive, is bringing its corporate Bitcoin curriculum to Oregon.

The after-work summit takes place in Lake Oswego on May 21, 2026. It’s built for CFOs, founders, treasurers, and business owners who seek a working grasp of how Bitcoin is reshaping corporate finance.

Publicly traded companies now hold more than 1.15 million BTC on their balance sheets, worth roughly $85 billion. Bitcoin ETFs now hold 1.28 million BTC collectively, and we believe the largest corporate holder of Bitcoin has deployed $11.2 billion to acquire 142,000+ Bitcoin in 2026 alone, based on publicly available sources.

“Bitcoin and adjacent securities are transforming how businesses manage their treasuries,” said Jeff Walton CEO of True North and Chief Risk Officer of Strive. “We aim to educate the business leaders of today, about the financial landscape of the future.”

To learn more about the Bitcoin for Business event please visit https://tnorth.com/events/bitcoin-for-business-2026/.

About Strive

Strive is a structured finance company and institutional asset manager focused on disciplined capital allocation and long-term value creation. With Bitcoin as our hurdle rate for capital deployment, Strive is focused on increasing Bitcoin per share to outperform Bitcoin over the long run. Strive holds approximately 14,557 Bitcoin as of April 24, 2026.

Strive Asset Management, LLC, a direct, wholly owned subsidiary of Strive and an SEC-registered investment adviser, manages over $2.7 billion in assets. Learn more at strive.com.

Cautionary Statement Regarding Forward-Looking Statements

Certain statements herein may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 175 promulgated thereunder, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rule 3b-6 promulgated thereunder, which statements involve inherent risks and uncertainties. Examples of forward-looking statements include, but are not limited to, express or implied statements regarding the outlook and expectations of Strive and its subsidiaries, the strategic benefits and financial benefits of the merger transaction with Semler Scientific, Inc. (the "merger transaction"), including the expected impact of the merger transaction on Strive’s future financial performance and the ability to successfully integrate the combined businesses, and Strive’s intentions with respect to adjusting the SATA Stock monthly regular dividend rate per annum. Such statements are often characterized by the use of qualified words (and their derivatives) such as “may,” “will,” “anticipate,” “could,” “should,” “would,” “believe,” “contemplate,” “expect,” “estimate,” “continue,” “plan,” “project,” “predict,” “potential,” “assume,” “forecast,” “target,” “budget,” “outlook,” “trend,” “guidance,” “objective,” “goal,” “strategy,” “opportunity,” and “intend,” as well as words of similar meaning or other statements concerning opinions or judgments of Strive and its respective management team about future events. Forward-looking statements are based on assumptions as of the time they are made and are subject to risks, uncertainties and other factors that are difficult to predict with regard to timing, extent, likelihood and degree of occurrence, which could cause actual results to differ materially from anticipated results expressed or implied by such forward-looking statements as a result of various important factors. Other risks, uncertainties and assumptions, including, among others, the following:

the outcome of any legal proceedings that may be instituted against Strive or its subsidiaries;the possibility that the anticipated benefits of the merger transaction are not realized when expected or at all, including as a result of changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets, general economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement;the diversion of management’s attention from ongoing business operations and opportunities;dilution caused by Strive’s issuance of additional shares of its Class A common stock or SATA Stock;potential adverse reactions of Strive’s clients and customers or changes to business or employee relationships, including those resulting from the completion of the merger transaction;other factors that may affect future results of Strive or the future trading performance of its Class A common stock or SATA Stock. These factors are not necessarily all of the factors that could cause Strive’s actual results, performance or achievements to differ materially from those expressed in or implied by any of the forward-looking statements. Other factors, including unknown or unpredictable factors, also could harm Strive’s results.

Although Strive believes that its expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of its existing knowledge of its business and operations, there can be no assurance that the actual results of Strive will not differ materially from any projected future results expressed or implied by such forward-looking statements. Additional factors that could cause results to differ materially from those described above can be found in Strive’s Annual Report on Form 10-K, for the fiscal year ended December 31, 2025 and other documents subsequently filed by Strive with the SEC.

The actual results anticipated may not be realized or, even if substantially realized, they may not have the expected consequences to or effects on Strive or its businesses or operations. Investors are cautioned not to rely too heavily on any such forward-looking statements. Forward-looking statements contained herein speak only as of the date hereof, and Strive undertakes no obligation to update or clarify these forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required by applicable law.

Strive Media Contact:
[email protected]

Investor Contact:
[email protected]

Source: Strive, Inc.

DALLAS, May 14, 2026 (GLOBE NEWSWIRE) -- Strive, Inc. (Nasdaq: ASST; SATA) (“Strive” or the “Company”) today announced that it will begin paying dividends on its Variable Rate Series A Perpetual Preferred Stock (the "SATA Stock") on a daily basis. This change will take effect on June 16, 2026, with dividends paid each business day to stockholders of record on the immediately preceding business day. Dividend, if and when declared, will be declared on a monthly basis for the following month's monthly dividend period. The Company's board of directors maintained the regular dividend rate per annum on the Company's SATA Stock at 13.00%, effective for the monthly periods commencing on or after May 16, 2026. The Company also announced its financial results for the first quarter ended March 31, 2026.

Key Highlights:

Acquired a total of 6,001 bitcoin during the first quarter ended March 31, 2026, including 5,048 bitcoin from the acquisition of Semler Scientific, Inc. and 953 bitcoin from open market purchases.Acquired an additional 1,381 bitcoin during the period from April 1, 2026 through May 12, 2026.
Since Strive's announcement on May 4, 2026, Strive has acquired an additional 9 bitcoin, bringing our total bitcoin treasury to 15,009 bitcoin. Achieved a Bitcoin Yield of 11.1% in Q1 2026 and 4.6% QTD (as of May 12, 2026) in Q2 2026.Generated a Bitcoin Gain of ₿848 BTC in Q1 2026 and ₿621 QTD (as of May 12, 2026) in Q2 2026.Generated a Bitcoin $ Gain of $57.8 million in Q1 2026 and $50.1 million QTD (as of May 12, 2026) in Q2 2026.As of May 12, 2026, Strive's cash and cash equivalents totaled $87.6 million and our position in Variable Rate Series A Perpetual Preferred Stock of Strategy Inc. ("STRC Stock") had a fair value of $50.5 million. Strive had 63,211,995 and 9,870,636 shares of Class A common stock and Class B common stock, respectively, and 4,959,536 shares of SATA Stock outstanding as of May 12, 2026.During the period from April 1, 2026 to May 12, 2026, the Company repurchased the remaining balance of long-term notes payable, at fair value. As of May 12, 2026, the Company has no short or long-term debt outstanding.Consummated the acquisition of Semler Scientific, Inc. ("Semler Scientific") in an all-stock transaction, resulting in Strive acquiring the approximately 5,048 bitcoin held by Semler Scientific. Strive intends to monetize the business as it remains focused on its bitcoin accumulation strategy.On January 27, 2026, the Company completed a follow-on registered public offering of 1,320,000 shares of its SATA Stock at a price to the public of $90.00 per share, resulting in net proceeds of approximately $109.3 million, after deducting the underwriting discounts and commissions and the Company’s offering expenses. Strive utilized these proceeds, along with cash on hand, to retire the $20 million loan with Coinbase Credit Inc., which Strive assumed as part of the acquisition of Semler Scientific. Concurrent with the above public offering, Strive exchanged approximately 929,999 shares of SATA Stock, with a $93.0 million notional balance, for $90.0 million of the principal balance of the convertible notes assumed as part of the acquisition of Semler Scientific, representing 90.0% of the principal balance of the convertible debt principal balance assumed from Semler Scientific.GAAP net loss of $265.9 million, for the three months ended March 31, 2026. $295.8 million (96.6%) of the GAAP net loss was attributable to the fair market value decrease in bitcoin holdings.Non-GAAP adjusted net loss attributable to common stockholders1 of $319.7 million, or $5.19 per diluted common share1, for the three months ended March 31, 2026. $295.8 million (92.5%) of the $319.7 million non-GAAP adjusted net loss attributable to common stockholders was attributable to the fair market value decrease in bitcoin holdings and $13.7 million (7.5%) was attributable to other business operations. Non-GAAP adjusted net loss attributable to common stockholders subtracts non-recurring and non-cash items from GAAP net loss attributable to common stockholders. "SATA will be the first listed security in the history of U.S. capital markets to pay cash dividends every single Business Day, beginning June 16, 2026, at a current annualized rate of 13.00%. This is a true zero-to-one innovation," said Matthew Cole, Chairman & Chief Executive Officer of Strive, Inc. "Today, Strive stands debt-free, with zero margin requirements, and zero encumbered Bitcoin; a balance sheet purpose-built to thrive through Bitcoin volatility. We're thrilled to unveil the next chapter for Strive: The Daily Dividend Company."

   (1) Non-GAAP adjusted net loss, non-GAAP adjusted net loss attributable to common stockholders, and non-GAAP adjusted net loss per diluted common share are non-GAAP measures. See page 4 for reconciliations of these non-GAAP financial measures to the most comparable GAAP financial measures. STRIVE, INC.
CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION
(in thousands, except share and per share data)
  March 31,
2026 December 31,
2025 (unaudited) (audited)Assets:   Current assets:   Cash and cash equivalents$95,092  $67,499 Investments in preferred equity, at fair value 50,510   — Prepaid expenses 2,590   2,708 Other current assets 2,787   1,569 Total current assets 150,979   71,776 Digital assets, at fair value 929,396   668,486 Property and equipment, net 872   778 Intangible assets, net 14,994   355 Right-of-use lease assets 3,932   4,037 Other non-current assets 96   95 Total assets$1,100,269  $745,527     Liabilities:   Current liabilities:   Compensation and benefits payable$3,667  $164 Accounts payable and other liabilities 4,881   8,560 Dividends payable 4,647   2,053 Total current liabilities 13,195   10,777 Long-term notes payable, at fair value 9,701   — Operating lease liabilities 3,416   3,512 Total liabilities 26,312   14,289     Mezzanine equity:   Variable Rate Series A Preferred Stock, $0.001 par value; 20,000,000 shares authorized,
4,373,194 and 2,012,729 shares issued and outstanding, $437.3 million and $201.3 million
redemption value and liquidation preference as of March 31, 2026 and December 31, 2025,
respectively 359,174   148,802 Total mezzanine equity 359,174   148,802     Stockholders’ equity:   Class A common stock, $0.001 par value; 22,200,000,000 shares authorized, 59,286,628 and
34,936,745 shares issued and outstanding as of March 31, 2026 and December 31, 2025,
respectively 59   699 Class B common stock, $0.001 par value; 1,050,000,000 shares authorized, 9,872,157 and
9,776,540 shares issued and outstanding as of March 31, 2026 and December 31, 2025,
respectively 10   196 Additional paid-in capital 1,468,128   1,055,595 Accumulated deficit (753,414)  (474,054)Total stockholders’ equity 714,783   582,436 Total liabilities, mezzanine equity, and stockholders' equity$1,100,269  $745,527  STRIVE, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share data)
(unaudited)
  Successor  Predecessor Three Months Ended
March 31, 2026  Three Months Ended
March 31, 2025Revenues:    Investment advisory fees$1,347   $1,416 Medical device revenues 1,370    — Other revenue 43    7 Total revenues 2,760    1,423      Operating expenses:    Fund management and administration 1,424    1,411 Employee compensation and benefits 13,053    2,066 General and administrative expense 5,938    1,906 Marketing and advertising 116    61 Depreciation and amortization 90    52 Total operating expenses 20,621    5,496      Investment gains/(losses):    Net unrealized loss on digital assets, at fair value (295,778)   — Net unrealized gain on investments in preferred equity, at fair value 490    — Total investment gains/(losses), net (295,288)   —      Net operating loss (313,149)   (4,073)     Other income/(expense):    Other income 526    324 Interest expense on long-term notes payable, at fair value (242)   — Change in fair value on long-term notes payable, at fair value (2,165)   — Loss on extinguishment of debt (8,461)   — Loss on change in fair value of bitcoin held as collateral under Coinbase Loan (2,594)   — Transaction costs (6,525)   — Bargain purchase gain 66,704    — Total other income, net 47,243    324      Net loss before income taxes (265,906)   (3,749)Income tax benefit/(expense) —    — Net loss$(265,906)  $(3,749)Dividends on preferred stock (13,454)   — Net loss attributable to common stockholders$(279,360)  $(3,749)     Weighted average number of common shares outstanding:    Basic(1) 61,630,003    2,275,940 Diluted(1) 61,630,003    2,275,940      Net loss per common share:    Basic(1)$(4.53)  $(1.65)Diluted(1)$(4.53)  $(1.65) (1) Basic and diluted earnings per common share for Class A and Class B common stock are the same.

Non-GAAP Financial Measures

This press release contains certain non-GAAP financial measures, consisting of non-GAAP adjusted net income (loss), non-GAAP adjusted net income (loss) attributable to common stockholders and non-GAAP adjusted net income (loss) attributable to common stockholders per diluted common share. Non-GAAP financial measures are subject to material limitations as they are not measurements prepared in accordance with GAAP and are not a substitute for such measurements. Our non-GAAP financial measures are not meant to be considered in isolation and should be read only in conjunction with our consolidated financial statements, which have been prepared in accordance with GAAP. We rely primarily on such consolidated financial statements to understand, manage, and evaluate our business performance and use the non-GAAP financial measures as supplemental information. Reconciliations of reported GAAP historic measures to adjusted non-GAAP measures are included in the financial schedules contained in this press release.

Non-GAAP adjusted net income (loss)

Non-GAAP adjusted net income (loss), non-GAAP adjusted net income (loss) attributable to common stockholders, and the related non-GAAP adjusted net income (loss) per diluted common share excludes the impact of (i) share-based compensation expense, (ii) depreciation and amortization, (iii) change in fair value on long-term notes payable, at fair value, (iv) loss on extinguishment of debt, (v) loss on change in fair value of bitcoin held as collateral under Coinbase Loan, (vi) transaction costs, and (vii) bargain purchase gain. We believe these measures offer management and investors insight as they exclude significant non-cash and/or non-recurring items. The following provides GAAP measures of net loss, net loss attributable to common stockholders, and net loss per diluted common share and the details with respect to reconciling the line items to non-GAAP adjusted net income (loss), non-GAAP adjusted net income (loss) attributable to common stockholders, and non-GAAP adjusted net income (loss) per diluted common share (all amounts in thousands, other than share and per share information):

 Successor  Predecessor Three Months Ended
March 31, 2026  Three Months Ended
March 31, 2025Net loss$(265,906)  $(3,749)Share-based compensation expense 6,529    — Depreciation and amortization 90    52 Change in fair value on long-term notes payable, at fair value 2,165    — Loss on extinguishment of debt 8,461    — Loss on change in fair value of bitcoin held as collateral under Coinbase Loan 2,594    — Transaction costs 6,525    — Bargain purchase gain (66,704)   — Non-GAAP adjusted net income (loss)$(306,246)  $(3,697)Dividends on preferred stock (13,454)   — Non-GAAP adjusted net loss attributable to common stockholders$(319,700)  $(3,697)     Weighted average number of diluted common shares outstanding 61,630,003    2,275,940 Net loss per diluted common share$(4.53)  $(1.65)Non-GAAP adjusted net loss per diluted common share$(5.19)  $(1.62)
Important Information About Other Metrics

Bitcoin Yield is a metric that represents the percentage change in bitcoin per share from the beginning of a period to the end of a period.

Bitcoin Gain is a metric that represents the number of bitcoin held by the Company at the beginning of a period multiplied by the Bitcoin Yield for such period.

Bitcoin $ Gain is a metric that represents the dollar value of the Bitcoin Gain calculated by multiplying the Bitcoin Gain by the market price of bitcoin. For determining Bitcoin $ Gain, unless otherwise specified, the Company uses the current market price of bitcoin. For determining Bitcoin $ Gain for a past fiscal year or other past period, the Company uses the market price of bitcoin as of 4:00pm ET as reported on the Coinbase exchange on the last day of the applicable period. The Company uses these market prices of bitcoin for this calculation solely for the purpose of facilitating this illustrative calculation.

The Company uses Bitcoin Yield, Bitcoin Gain and Bitcoin $ Gain as metrics to help assess the performance of its strategy of acquiring bitcoin in a manner the Company believes is accretive to stockholders. The Company believes these metrics can supplement investors’ understanding of how the Company chooses to fund bitcoin purchases and the value created in a period by:

in the case of Bitcoin Yield, measuring the percentage change in bitcoin per share from the beginning of a period to the end of a period, which helps investors assess how the Company’s achievement of its strategy of acquiring bitcoin in an accretive manner varies across periods;in the case of Bitcoin Gain, hypothetically expressing the percentage change reflected in the Bitcoin Yield metric as if it reflected an increase in the amount of bitcoin held at the end of the applicable period as compared to the beginning of such period, which provides investors with visibility into the absolute change in the Company’s bitcoin holdings resulting from its Bitcoin Yield; andin the case of Bitcoin $ Gain, further expressing that change as an illustrative dollar value by multiplying that bitcoin-denominated change by the market price of bitcoin at the end of the applicable period as described above. When the Company uses these metrics, management takes into account the various limitations of these metrics, including that they do not take into account that our assets, including our bitcoin, are subject to (i) all of our existing and future liabilities, including our debt, and (ii) the preferential rights of our preferred stockholders to dividends and our assets in a liquidation, and that all such claims rank senior to those of our common equity; and

Bitcoin Yield, Bitcoin Gain and Bitcoin $ Gain are not, and should not be understood as, financial performance, valuation or liquidity measures. Specifically:

Bitcoin Yield is not equivalent to “yield” in the traditional financial context. It is not a measure of the return on investment the Company’s stockholders may have achieved historically or can achieve in the future by purchasing stock of the Company, or a measure of income generated by the Company’s operations or its bitcoin holdings, return on investment on its bitcoin holdings, or any other similar financial measure of the performance of its business or assets.Bitcoin Gain and Bitcoin $ Gain are not equivalent to “gain” in the traditional financial context. They also are not measures of the return on investment the Company’s stockholders may have achieved historically or can achieve in the future by purchasing stock of the Company, or measures of income generated by the Company’s operations or its bitcoin holdings, return on investment on its bitcoin holdings, or any other similar financial measure of the performance of its business or assets. It should also be understood that Bitcoin $ Gain does not represent a fair value gain of the Company’s bitcoin holdings, and Bitcoin $ Gain may be positive during periods when the Company has incurred fair value losses on its bitcoin holdings. The trading price of the Company’s Class A common stock is informed by numerous factors in addition to Company’s bitcoin holdings and its actual or potential shares of Class A common stock outstanding, and as a result, the trading price of the Company’s securities can deviate significantly from the market value of the Company’s bitcoin, and none of Bitcoin Yield, Bitcoin Gain or Bitcoin $ Gain are indicative or predictive of the trading price of the Company’s securities.

Investors should rely on the financial statements and other disclosures contained in the Company’s SEC filings. In particular, the Company has adopted Accounting Standards Update No. 2023-08, Intangibles-Goodwill and Other-Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets (“ASU 2023-08”), which requires that the Company measure its bitcoin at fair value in its statement of financial position as of the end of a reported period, and recognize gains losses from changes in the fair value in net income (loss) for the reported period. As a result, we may incur unrealized gain or loss on digital assets based on changes in the market price of bitcoin during a period, which would not be reflected in Bitcoin Yield, Bitcoin Gain or Bitcoin $ Gain.

As noted above, these metrics are narrow in their purpose and are used by management to assist it in assessing whether the Company is raising and deploying capital in a manner accretive to stockholders solely as it pertains to its bitcoin holdings.

In calculating these metrics, the Company does not consider the source of capital used for the acquisition of its bitcoin. When the Company purchases bitcoin using proceeds from offerings of redeemable preferred stock, such transactions have the effect of increasing the Bitcoin Yield, Bitcoin Gain and Bitcoin $ Gain, while also increasing the Company’s senior claims of holders of instruments other than Class A common stock with respect to dividends and to the Company’s assets, including its bitcoin, in a manner that is not reflected in these metrics.

If any of the Company’s convertible notes mature or are redeemed without being converted into common stock, or if the Company elects to redeem or repurchase its non-convertible instruments, the Company may be required to sell shares of its Class A common stock or bitcoin to generate sufficient cash proceeds to satisfy those obligations, either of which would have the effect of decreasing Bitcoin Yield, Bitcoin Gain and Bitcoin $ Gain, and adjustments for such decreases are not contemplated by the assumptions made in calculating these metrics. Accordingly, these metrics might overstate or understate the accretive nature of the Company’s use of capital to buy bitcoin because not all bitcoin is purchased using proceeds of issuances of Class A common stock, and not all proceeds from issuances of Class A common stock are used to purchase bitcoin.

In addition, we are required to pay dividends with respect to our perpetual preferred stock in perpetuity. The Company has historically not paid any dividends on its shares of Class A common stock, and by presenting these metrics the Company makes no suggestion that it intends to do so in the future. Ownership of the Company’s securities, including its Class A common stock and preferred stock, does not represent an ownership interest in, or a redemption right with respect to, the bitcoin the Company holds.

The Company’s ability to achieve positive Bitcoin Yield, Bitcoin Gain, or Bitcoin $ Gain may depend on a variety of factors, including factors outside of its control, such as the price of bitcoin, and the availability of debt and equity financing on favorable terms. Past performance is not indicative of future results.

These metrics are merely supplements, not substitutes to the financial statements and other disclosures contained in the Company’s SEC filings. They should be used only by sophisticated investors who understand their limited purpose and many limitations.

About Strive

Strive is a structured finance company and institutional asset manager focused on disciplined capital allocation and long-term value creation. With bitcoin as our hurdle rate for capital deployment, Strive is focused on increasing bitcoin per share to outperform bitcoin over the long run.

Strive Asset Management, LLC, a direct, wholly owned subsidiary of Strive and an SEC-registered investment adviser, manages over $2.7 billion in assets. Learn more at strive.com.

Cautionary Statement Regarding Forward-Looking Statements

Certain statements herein may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 175 promulgated thereunder, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rule 3b-6 promulgated thereunder, which statements involve inherent risks and uncertainties. Examples of forward-looking statements include, but are not limited to, express or implied statements regarding the outlook and expectations of Strive and its subsidiaries, the strategic benefits and financial benefits of the merger transaction with Semler Scientific, Inc. (the "merger transaction"), including the expected impact of the merger transaction on Strive’s future financial performance and the ability to successfully integrate the combined businesses, and Strive’s intentions with respect to adjusting the SATA Stock monthly regular dividend rate per annum. Such statements are often characterized by the use of qualified words (and their derivatives) such as “may,” “will,” “anticipate,” “could,” “should,” “would,” “believe,” “contemplate,” “expect,” “estimate,” “continue,” “plan,” “project,” “predict,” “potential,” “assume,” “forecast,” “target,” “budget,” “outlook,” “trend,” “guidance,” “objective,” “goal,” “strategy,” “opportunity,” and “intend,” as well as words of similar meaning or other statements concerning opinions or judgments of Strive and its respective management team about future events. Forward-looking statements are based on assumptions as of the time they are made and are subject to risks, uncertainties and other factors that are difficult to predict with regard to timing, extent, likelihood and degree of occurrence, which could cause actual results to differ materially from anticipated results expressed or implied by such forward-looking statements as a result of various important factors. Other risks, uncertainties and assumptions, including, among others, the following:

the outcome of any legal proceedings that may be instituted against Strive or its subsidiaries;the possibility that the anticipated benefits of the merger transaction are not realized when expected or at all, including as a result of changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets, general economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement;the diversion of management’s attention from ongoing business operations and opportunities;dilution caused by Strive’s issuance of additional shares of its Class A common stock or SATA Stock;potential adverse reactions of Strive’s clients and customers or changes to business or employee relationships, including those resulting from the completion of the merger transaction;other factors that may affect future results of Strive or the future trading performance of its Class A common stock or SATA Stock. These factors are not necessarily all of the factors that could cause Strive’s actual results, performance or achievements to differ materially from those expressed in or implied by any of the forward-looking statements. Other factors, including unknown or unpredictable factors, also could harm Strive’s results.

Although Strive believes that its expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of its existing knowledge of its business and operations, there can be no assurance that the actual results of Strive will not differ materially from any projected future results expressed or implied by such forward-looking statements. Additional factors that could cause results to differ materially from those described above can be found in Strive’s Annual Report on Form 10-K, for the fiscal year ended December 31, 2025 and other documents subsequently filed by Strive with the SEC.

The actual results anticipated may not be realized or, even if substantially realized, they may not have the expected consequences to or effects on Strive or its businesses or operations. Investors are cautioned not to rely too heavily on any such forward-looking statements. Forward-looking statements contained herein speak only as of the date hereof, and Strive undertakes no obligation to update or clarify these forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required by applicable law.

Strive Media Contact:
[email protected]

Investor Contact:
[email protected]

A downtrend has been apparent in Strive, Inc. (ASST - Free Report) lately. While the stock has lost 5.3% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last trading session. This could mean that the bulls have been able to counteract the bears to help the stock find support.

While the formation of a hammer pattern is a technical indication of nearing a bottom with potential exhaustion of selling pressure, rising optimism among Wall Street analysts about the future earnings of this company is a solid fundamental factor that enhances the prospects of a trend reversal for the stock.

What is a Hammer Chart and How to Trade It?This is one of the popular price patterns in candlestick charting. A minor difference between the opening and closing prices forms a small candle body, and a higher difference between the low of the day and the open or close forms a long lower wick (or vertical line). The length of the lower wick being at least twice the length of the real body, the candle resembles a 'hammer.'

In simple terms, during a downtrend, with bears having absolute control, a stock usually opens lower compared to the previous day's close, and again closes lower. On the day the hammer pattern is formed, maintaining the downtrend, the stock makes a new low. However, after eventually finding support at the low of the day, some amount of buying interest emerges, pushing the stock up to close the session near or slightly above its opening price.

When it occurs at the bottom of a downtrend, this pattern signals that the bears might have lost control over the price. And, the success of bulls in stopping the price from falling further indicates a potential trend reversal.

Hammer candles can occur on any timeframe -- such as one-minute, daily, weekly -- and are utilized by both short-term as well as long-term investors.

Like every technical indicator, the hammer chart pattern has its limitations. Particularly, as the strength of a hammer depends on its placement on the chart, it should always be used in conjunction with other bullish indicators.

Here's What Makes the Trend Reversal More Likely for ASSTThere has been an upward trend in earnings estimate revisions for ASST lately, which can certainly be considered a bullish indicator on the fundamental side. That's because a positive trend in earnings estimate revisions usually translates into price appreciation in the near term.

The consensus EPS estimate for the current year has increased 61.9% over the last 30 days. This means that the Wall Street analysts covering ASST are majorly in agreement about the company's potential to report better earnings than what they predicted earlier.

If this is not enough, you should note that ASST currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. And stocks carrying a Zacks Rank #1 or 2 usually outperform the market. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Moreover, the Zacks Rank has proven to be an excellent timing indicator, helping investors identify precisely when a company's prospects are beginning to improve. So, for the shares of Strive, Inc., a Zacks Rank of 2 is a more conclusive fundamental indication of a potential turnaround.

Posted by Defense World Staff on Apr 3rd, 2026

Eldred Rock Partners LLC cut its holdings in shares of Ambev S.A. (NYSE:ABEV – Free Report) by 10.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,560,200 shares of the company’s stock after selling 401,846 shares during the quarter. Ambev comprises approximately 2.3% of Eldred Rock Partners LLC’s investment portfolio, making the stock its 26th biggest position. Eldred Rock Partners LLC’s holdings in Ambev were worth $8,794,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. CANADA LIFE ASSURANCE Co raised its holdings in Ambev by 74.8% in the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 13,409,316 shares of the company’s stock valued at $32,624,000 after buying an additional 5,740,155 shares during the period. Massachusetts Financial Services Co. MA boosted its stake in Ambev by 12.0% during the third quarter. Massachusetts Financial Services Co. MA now owns 36,058,376 shares of the company’s stock worth $80,410,000 after buying an additional 3,864,844 shares during the period. Marshall Wace LLP increased its position in shares of Ambev by 192.7% during the second quarter. Marshall Wace LLP now owns 4,208,299 shares of the company’s stock valued at $10,142,000 after acquiring an additional 2,770,698 shares during the last quarter. Bank of America Corp DE raised its stake in shares of Ambev by 9.9% in the 2nd quarter. Bank of America Corp DE now owns 27,505,192 shares of the company’s stock valued at $66,288,000 after acquiring an additional 2,479,310 shares during the period. Finally, Cubist Systematic Strategies LLC purchased a new stake in shares of Ambev in the 2nd quarter valued at approximately $5,124,000. 8.13% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In A number of equities analysts recently weighed in on ABEV shares. Weiss Ratings raised shares of Ambev from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, March 5th. Wall Street Zen cut Ambev from a “buy” rating to a “hold” rating in a research note on Monday. Finally, Barclays raised their price target on Ambev from $2.50 to $3.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 17th. One analyst has rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $2.69.

Get Our Latest Research Report on ABEV

Ambev Trading Down 0.8% NYSE ABEV opened at $2.95 on Friday. The firm has a 50 day simple moving average of $2.95 and a 200-day simple moving average of $2.59. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.73 and a current ratio of 0.96. Ambev S.A. has a one year low of $2.10 and a one year high of $3.24. The firm has a market cap of $46.41 billion, a price-to-earnings ratio of 16.36, a PEG ratio of 2.19 and a beta of 0.66.

Ambev (NYSE:ABEV – Get Free Report) last announced its earnings results on Friday, February 13th. The company reported $0.05 earnings per share for the quarter, hitting the consensus estimate of $0.05. The firm had revenue of $4.50 billion for the quarter, compared to the consensus estimate of $4.28 billion. Ambev had a net margin of 17.75% and a return on equity of 16.41%. Equities research analysts anticipate that Ambev S.A. will post 0.18 EPS for the current fiscal year.

Ambev Company Profile (Free Report)

Ambev (NYSE: ABEV) is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company’s core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.

The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.

Featured Stories Five stocks we like better than Ambev Want to see what other hedge funds are holding ABEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ambev S.A. (NYSE:ABEV – Free Report).

Receive News & Ratings for Ambev Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambev and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINETwist Bioscience Corporation (NASDAQ:TWST) Receives Average Rating of “Moderate Buy” from Analysts

NEXT HEADLINE »Eldred Rock Partners LLC Invests $6.18 Million in Pool Corporation $POOL

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.

In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.

However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects.

Our proprietary system currently recommends Ambev (ABEV - Free Report) as one such stock. This company not only has a favorable Growth Score, but also carries a top Zacks Rank.

Studies have shown that stocks with the best growth features consistently outperform the market. And returns are even better for stocks that possess the combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy).

While there are numerous reasons why the stock of this beverage company is a great growth pick right now, we have highlighted three of the most important factors below:

Earnings GrowthArguably nothing is more important than earnings growth, as surging profit levels is what most investors are after. And for growth investors, double-digit earnings growth is definitely preferable, and often an indication of strong prospects (and stock price gains) for the company under consideration.

While the historical EPS growth rate for Ambev is 1.3%, investors should actually focus on the projected growth. The company's EPS is expected to grow 5.6% this year, crushing the industry average, which calls for EPS growth of 3.8%.

Impressive Asset Utilization RatioGrowth investors often overlook asset utilization ratio, also known as sales-to-total-assets (S/TA) ratio, but it is an important feature of a real growth stock. This metric shows how efficiently a firm is utilizing its assets to generate sales.

Right now, Ambev has an S/TA ratio of 0.62, which means that the company gets $0.62 in sales for each dollar in assets. Comparing this to the industry average of 0.53, it can be said that the company is more efficient.

In addition to efficiency in generating sales, sales growth plays an important role. And Ambev is well positioned from a sales growth perspective too. The company's sales are expected to grow 14.7% this year versus the industry average of 0%.

Promising Earnings Estimate RevisionsSuperiority of a stock in terms of the metrics outlined above can be further validated by looking at the trend in earnings estimate revisions. A positive trend is of course favorable here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

The current-year earnings estimates for Ambev have been revising upward. The Zacks Consensus Estimate for the current year has surged 2.7% over the past month.

Bottom LineAmbev has not only earned a Growth Score of B based on a number of factors, including the ones discussed above, but it also carries a Zacks Rank #2 because of the positive earnings estimate revisions.

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

This combination indicates that Ambev is a potential outperformer and a solid choice for growth investors.

© Tapati Rinchumrus / Shutterstock.com

The WisdomTree Emerging Markets High Dividend Fund (NYSEARCA:DEM) offers income investors about 4% dividend yield sourced entirely from companies in developing economies, packaged in a single fund with $3.5 billion in net assets. For investors tired of domestic dividend stalwarts, the appeal is real. But the income mechanics here deserve a close look before treating this as a reliable paycheck.

The iconic Octávio Frias de Oliveira Bridge anchors the financial district skyline of São Paulo, a prominent emerging market. How DEM Selects and Weights Its Dividend Payers DEM tracks a fundamentally weighted index of the highest dividend-yielding stocks across emerging markets. Rather than weighting by market cap, the fund allocates based on each company’s share of total dividends paid within the index universe. This approach naturally tilts the portfolio toward mature, cash-generative businesses in financials, energy, and consumer staples, sectors that have historically paid the most cash to shareholders in developing markets.

The fund holds over 500 individual securities, which sounds like broad protection. But concentration still exists at the top. China Construction Bank alone represents 4.5% of the portfolio, and the top 15 holdings account for roughly a quarter of total assets. Geographic exposure spans China, Taiwan, Brazil, Saudi Arabia, Poland, India, and a dozen other markets, each carrying its own currency, regulatory, and political risk.

The Two Highlighted Holdings: ABEV and UMC Two of the fund’s named holdings, Ambev (NYSE:ABEV | ABEV Price Prediction) and United Microelectronics (NYSE:UMC), sit at positions 15 and 13 respectively, each carrying weights of roughly 1%. Together they illustrate the structural tensions running through the entire portfolio.

Ambev, Brazil’s dominant brewer, paid roughly $0.20 per share in total USD dividends across 2025, which matches its reported EPS of $0.20 almost exactly. A payout ratio near 100% leaves no margin for earnings softness. The company’s operating cash flow fell 6.3% year over year, and its cash balance dropped nearly 35%. Currency is the deeper issue: Ambev earns in Brazilian reals, and the BRL currently trades near 0.20 per U.S. dollar, while the company hedges at a rate of 5.50 BRL/USD. When the real weakens beyond that hedge level, USD-denominated dividends shrink. The December 2025 year-end payment of $0.13 per share was meaningfully larger than the three smaller quarterly payments, meaning income is lumpy, not steady.

United Microelectronics, a Taiwanese semiconductor foundry, has a more encouraging dividend record. Annual payments grew from $0.14 in 2020 to $0.59 in 2023, then moderated to $0.48 in 2025. With EPS of $0.52, the payout ratio runs around 92%, which is elevated for a capital-intensive chipmaker. UMC guided for $1.5 billion in 2026 capital expenditure, and utilization sits in the mid-70% range, meaning the business is not running at peak efficiency. CEO Jason Wang stated, “Going into the first quarter of 2026, we expect wafer demand to remain firm.” That confidence supports near-term dividend continuity, though the high payout leaves little room for a demand miss.

Total Return and the Currency Drag Both holdings have delivered strong price recoveries recently. Ambev shares are up about 27% recently, and UMC has gained roughly 27% over the same period. That price appreciation is a meaningful part of the total return story for DEM holders, since the income alone carries real risks. The fund’s about 0.6% expense ratio erodes net yield meaningfully at the 4% income level.

The Verdict on DEM’s Income Stream DEM’s roughly 4.07% yield is real, but it is not stable. The fund’s income fluctuates with foreign currencies, corporate earnings cycles across a dozen emerging economies, and the dividend policies of companies operating under political and regulatory environments outside U.S. investor control. High payout ratios, currency translation risk, and lumpy payment schedules make budgeting around this income difficult.

Investors weighing DEM should understand that the yield comes bundled with variable quarterly distributions, currency translation risk across a dozen markets, and dividend policies set by companies operating under political and regulatory environments outside U.S. investor control. The gap between the fund’s headline yield and a U.S. Treasury reflects those risks directly.

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.

By their very nature, these stocks carry above-average risk and volatility. Moreover, if a company's growth story is over or nearing its end, betting on it could lead to significant loss.

However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects.

Ambev (ABEV - Free Report) is on the list of such stocks currently recommended by our proprietary system. In addition to a favorable Growth Score, it carries a top Zacks Rank.

Studies have shown that stocks with the best growth features consistently outperform the market. And returns are even better for stocks that possess the combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy).

While there are numerous reasons why the stock of this beverage company is a great growth pick right now, we have highlighted three of the most important factors below:

Earnings GrowthEarnings growth is arguably the most important factor, as stocks exhibiting exceptionally surging profit levels tend to attract the attention of most investors. For growth investors, double-digit earnings growth is highly preferable, as it is often perceived as an indication of strong prospects (and stock price gains) for the company under consideration.

While the historical EPS growth rate for Ambev is 1.3%, investors should actually focus on the projected growth. The company's EPS is expected to grow 5.6% this year, crushing the industry average, which calls for EPS growth of 2.8%.

Impressive Asset Utilization RatioAsset utilization ratio -- also known as sales-to-total-assets (S/TA) ratio -- is often overlooked by investors, but it is an important indicator in growth investing. This metric exhibits how efficiently a firm is utilizing its assets to generate sales.

Right now, Ambev has an S/TA ratio of 0.62, which means that the company gets $0.62 in sales for each dollar in assets. Comparing this to the industry average of 0.53, it can be said that the company is more efficient.

While the level of efficiency in generating sales matters a lot, so does the sales growth of a company. And Ambev is well positioned from a sales growth perspective too. The company's sales are expected to grow 14.7% this year versus the industry average of 0%.

Promising Earnings Estimate RevisionsSuperiority of a stock in terms of the metrics outlined above can be further validated by looking at the trend in earnings estimate revisions. A positive trend is of course favorable here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

The current-year earnings estimates for Ambev have been revising upward. The Zacks Consensus Estimate for the current year has surged 2.7% over the past month.

Bottom LineWhile the overall earnings estimate revisions have made Ambev a Zacks Rank #2 stock, it has earned itself a Growth Score of B based on a number of factors, including the ones discussed above.

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

This combination indicates that Ambev is a potential outperformer and a solid choice for growth investors.

The Consumer Staples group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Ambev (ABEV - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Consumer Staples sector should help us answer this question.

Ambev is a member of our Consumer Staples group, which includes 173 different companies and currently sits at #15 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.

The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Ambev is currently sporting a Zacks Rank of #2 (Buy).

Over the past three months, the Zacks Consensus Estimate for ABEV's full-year earnings has moved 5.6% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.

Based on the latest available data, ABEV has gained about 17.4% so far this year. Meanwhile, stocks in the Consumer Staples group have gained about 5.6% on average. This means that Ambev is performing better than its sector in terms of year-to-date returns.

Another Consumer Staples stock, which has outperformed the sector so far this year, is Chefs' Warehouse (CHEF - Free Report) . The stock has returned 26.5% year-to-date.

For Chefs' Warehouse, the consensus EPS estimate for the current year has increased 7% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy).

Looking more specifically, Ambev belongs to the Beverages - Alcohol industry, a group that includes 14 individual stocks and currently sits at #197 in the Zacks Industry Rank. On average, stocks in this group have gained 9.8% this year, meaning that ABEV is performing better in terms of year-to-date returns.

Chefs' Warehouse, however, belongs to the Food - Miscellaneous industry. Currently, this 41-stock industry is ranked #205. The industry has moved -2.5% so far this year.

Going forward, investors interested in Consumer Staples stocks should continue to pay close attention to Ambev and Chefs' Warehouse as they could maintain their solid performance.

Ambev S.A. has sharply rebounded on improved Brazilian macro, BRL strength, and renewed EM equity appetite, supported by strong FY25 and 1Q26 results. ABEV outperformed the declining Brazilian beer industry in Q1, with Brazil Beer volumes up 1.2% and premium segment growth exceeding 20%. Cash flow generation reached a decade-high in Q1, enabling robust shareholder returns with a 5–6% yield, well above minimum payout requirements.

Investors interested in stocks from the Beverages - Alcohol sector have probably already heard of Ambev (ABEV - Free Report) and Boston Beer (SAM - Free Report) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.

The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.

Currently, Ambev has a Zacks Rank of #2 (Buy), while Boston Beer has a Zacks Rank of #4 (Sell). Investors should feel comfortable knowing that ABEV likely has seen a stronger improvement to its earnings outlook than SAM has recently. But this is just one piece of the puzzle for value investors.

Value investors analyze a variety of traditional, tried-and-true metrics to help find companies that they believe are undervalued at their current share price levels.

The Value category of the Style Scores system identifies undervalued companies by looking at a number of key metrics. These include the long-favored P/E ratio, P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that help us determine a company's fair value.

ABEV currently has a forward P/E ratio of 17.59, while SAM has a forward P/E of 21.11. We also note that ABEV has a PEG ratio of 2.40. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. SAM currently has a PEG ratio of 2.66.

Another notable valuation metric for ABEV is its P/B ratio of 3.13. The P/B ratio is used to compare a stock's market value with its book value, which is defined as total assets minus total liabilities. For comparison, SAM has a P/B of 3.16.

These metrics, and several others, help ABEV earn a Value grade of B, while SAM has been given a Value grade of C.

ABEV has seen stronger estimate revision activity and sports more attractive valuation metrics than SAM, so it seems like value investors will conclude that ABEV is the superior option right now.

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.

That's because, these stocks usually carry above-average risk and volatility. In fact, betting on a stock for which the growth story is actually over or nearing its end could lead to significant loss.

However, the task of finding cutting-edge growth stocks is made easy with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects.

Our proprietary system currently recommends Ambev (ABEV - Free Report) as one such stock. This company not only has a favorable Growth Score, but also carries a top Zacks Rank.

Research shows that stocks carrying the best growth features consistently beat the market. And for stocks that have a combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy), returns are even better.

While there are numerous reasons why the stock of this beverage company is a great growth pick right now, we have highlighted three of the most important factors below:

Earnings GrowthArguably nothing is more important than earnings growth, as surging profit levels is what most investors are after. For growth investors, double-digit earnings growth is highly preferable, as it is often perceived as an indication of strong prospects (and stock price gains) for the company under consideration.

While the historical EPS growth rate for Ambev is 0.6%, investors should actually focus on the projected growth. The company's EPS is expected to grow 14.8% this year, crushing the industry average, which calls for EPS growth of 2.8%.

Impressive Asset Utilization RatioAsset utilization ratio -- also known as sales-to-total-assets (S/TA) ratio -- is often overlooked by investors, but it is an important indicator in growth investing. This metric exhibits how efficiently a firm is utilizing its assets to generate sales.

Right now, Ambev has an S/TA ratio of 0.62, which means that the company gets $0.62 in sales for each dollar in assets. Comparing this to the industry average of 0.48, it can be said that the company is more efficient.

While the level of efficiency in generating sales matters a lot, so does the sales growth of a company. And Ambev is well positioned from a sales growth perspective too. The company's sales are expected to grow 19.1% this year versus the industry average of 0%.

Promising Earnings Estimate RevisionsBeyond the metrics outlined above, investors should consider the trend in earnings estimate revisions. A positive trend is a plus here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

The current-year earnings estimates for Ambev have been revising upward. The Zacks Consensus Estimate for the current year has surged 8.8% over the past month.

Bottom LineAmbev has not only earned a Growth Score of B based on a number of factors, including the ones discussed above, but it also carries a Zacks Rank #2 because of the positive earnings estimate revisions.

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

This combination positions Ambev well for outperformance, so growth investors may want to bet on it.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

© jittawit21 / Shutterstock.com

Single digit share prices usually mean a broken business, a melting ice cube, or a speculative lottery ticket. Every once in a while though, the market hands you something genuinely strange: a household name with billions in cash flow and a serious dividend, trading for the price of a fancy coffee. With Wall Street nervous about Latin American currencies and Brazil’s interest rate environment, one of the biggest beverage businesses on the planet has quietly slipped into bargain territory.

With that setup, here is one stock trading under $5 that long-term, income-focused investors should be paying close attention to right now.

Ambev (NYSE: ABEV) Ambev (NYSE:ABEV | ABEV Price Prediction) is the Brazilian brewing and beverage giant behind Brahma, Skol, Antarctica, Stella Artois, Corona, Budweiser, and Michelob Ultra across Latin America, plus the licensed Pepsi business in Brazil and digital platforms BEES Marketplace and Zé Delivery.

Shares closed at $3.27 on May 21, 2026, which means a $500 grocery budget can buy you a meaningful stake in a company with a market cap near $50.92 billion. The stock is up 32.39% year to date and 39.23% over the past year, yet it still trades closer to the middle of its 52-week range of $1.988 to $3.45.

This infographic provides a snapshot of ABEV, highlighting its current price, analyst consensus, and price targets as a ‘Buy’ case stock trading under $5. The fundamentals tell you why this is more than a penny stock dressed up in a suit. Ambev generated $88.24 billion in FY2025 revenue and $15.99 billion in net income, up 10.74% year over year. The company trades at a trailing P/E of 16 and a forward P/E of 15, with a dividend yield of 4.79%. Analysts surveyed for the stock skew cautious overall: 1 Strong Buy, 1 Buy, 7 Hold, and 2 Sell ratings, with an average price target of $3.326, roughly in line with where shares trade today.

The bull case is straightforward. Buying market dominance at a single-digit share price is rare, and Ambev controls a functional monopoly over the Latin American beverage market. The company returned roughly $20 billion in dividends and buybacks for FY25, approved a new R$2.5 billion buyback authorizing up to 208 million shares, and re-elected its board through 2029. Premium brand volumes climbed 17% for the full year, non-alcohol beer volumes grew about 30% in Brazil, and Zé Delivery now does R$4.7 billion in GMV with 67 million yearly orders and 27 million active users. CEO Carlos Lisboa said “the strength of our brands and the consistent execution of our strategy drove mid-single-digit Normalized EBITDA growth with margin expansion, despite a dynamic environment”. The 2026 FIFA World Cup is the cherry on top: a global beer-drinking event landing right as Ambev enters the year with momentum.

The risk that cuts against this thesis is real. Goldman Sachs has maintained a Sell rating tied to Brazil’s cost-of-capital concerns, consolidated volumes fell 3.6% in Q4 and 3.3% for the full year, and management guided Brazil Beer Cash COGS per hectoliter up 4.5% to 7.5% in 2026. FX swings, aluminum costs, and Argentina’s hyperinflation are not going away. Currency fluctuations and temporary regional headwinds scare off short-sighted institutional funds, but the company’s massive scale, pristine balance sheet, and reliable cash generation yield a highly stable 4.5%+ dividend for value seekers.

For investors willing to look past short-term Brazil noise, Ambev offers a rare combination: regional dominance, real cash returns, and a single-digit share price that does the heavy lifting on entry cost.

One last reminder: Ambev’s case rests on its scale, its cash flow, and its dividend. The single-digit share price is just the entry cost, not the investment thesis itself. Do your own digging on the FX exposure and Brazilian macro picture before you decide whether this fits your portfolio.

Ambev S.A. recently rallied to a one-year high, with a subsequent pullback presenting renewed buying opportunities. ABEV's Q1 2026 showed resilience: operating revenue was stable, organic net revenue per hectoliter rose 8%, and operating margin improved to 26.5%. Inflation and shifting consumer preferences, especially among younger Americans, remain key risks, but ABEV's Brazilian market strength and diversification mitigate these concerns.

GigaCloud Technology Inc. delivered strong Q1 '26 results, with 32% y/y revenue growth and beats on both top and bottom lines. GCT's European expansion, especially in Germany, is driving impressive segment growth and underpins the company's strategic outlook. The company maintains a robust balance sheet with $330m in cash, no long-term debt, and intentional inventory buildup ahead of seasonal demand.

May 08, 2026 07:00 ET  | Source: GigaCloud Technology

EL MONTE, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce technology solutions for large parcel merchandise, today announced that Larry Wu, its Founder and Chief Executive Officer, will present at the 21st Annual Needham Technology, Media, & Consumer Conference on Thursday, May 14, 2026, at 2:15 p.m. ET/11:15 a.m. PT.

The virtual presentation will be webcast at https://investors.gigacloudtech.com/ and will be available for replay for 90 days after the live event ends.

GigaCloud also will conduct virtual one-on-one meetings with investors throughout the day. To schedule a meeting, please contact your Needham representative, or PondelWilkinson at [email protected].

About GigaCloud Technology Inc

GigaCloud Technology Inc is a pioneer of global end-to-end B2B ecommerce technology solutions for large parcel merchandise. The Company’s B2B ecommerce platform, which it refers to as the “GigaCloud Marketplace,” integrates everything from discovery, payments and logistics tools into one easy-to-use platform. The Company’s global marketplace seamlessly connects manufacturers, primarily in Asia, with resellers, primarily in the U.S., Asia and Europe, to execute cross-border transactions with confidence, speed and efficiency. The Company offers a truly comprehensive solution that transports products from the manufacturer’s warehouse to the end customer’s doorstep, all at one fixed price. The Company first launched its marketplace in January 2019 by focusing on the global furniture market and has since expanded into additional categories such as home appliances and fitness equipment. For more information, please visit the Company’s website: https://investors.gigacloudtech.com/.

For investor and media inquiries, please contact:

GigaCloud Technology Inc

Investor Relations - [email protected]

PondelWilkinson Inc.

Todd Kehrli (Investors) – [email protected]
Laurie Berman (Investors) – [email protected]
George Medici (Media) – [email protected]

Key Takeaways GCT posted Q1 EPS of $1.04 on $359.5M revenues, beating consensus estimates. GigaCloud Technology's GMV hit $1.7B TTM; active buyers rose 25% and sellers 19%. GCT guided Q2 revenues to $365M-$390M, partnered with Otto Group, and bought back $12.3M shares. Last week, GigaCloud Technology (GCT - Free Report) reported first-quarter 2026 earnings that exceeded expectations, driven by robust demand, enhanced operational efficiency and solid profitability within its platform-based B2B business model. The company’s strong second-quarter revenue outlook further indicates sustained business momentum.

Before examining the key drivers behind this strong performance amid continued economic uncertainty, let’s first take a closer look at the first-quarter results.

GCT’s Q1 Earnings OverviewGigaCloud Technology posted earnings per share of $1.04, surpassing the Zacks Consensus Estimate of 87 cents. The bottom line jumped 52.9% year over year. Supported by strong demand trends, quarterly revenues climbed 32.2% from the year-ago quarter to $359.5 million, ahead of the Zacks Consensus Estimate of $344.9 million.

Gross profit rose 34.7% year over year to $85.8 million. GCT’s marketplace business continued to witness strong momentum, underscoring its growing market relevance and expanding scale. Gross merchandise value (“GMV”) increased 17% year over year on a trailing 12-month basis ended March 31, 2026, reaching $1.7 billion, reflecting stronger transaction activity and rising buyer engagement.

The company’s marketplace ecosystem also continued to expand, with active third-party sellers increasing 19% to 1,377, thereby broadening product offerings for customers. Active buyers grew 25% to 12,473, indicating solid demand trends and an expanding customer base.

For the second quarter of 2026, the company projects total revenues in the range of $365 million to $390 million. GigaCloud Technology also remained proactive in returning value to shareholders, repurchasing 304,321 Class A ordinary shares for approximately $12.3 million during the March quarter, highlighting its shareholder-friendly approach.

The strong March-quarter performance enabled the company to preserve its impressive earnings surprise track record.

<Image Source: Zacks Investment Research

Additional Factors Supporting a Bullish View on GCT StockStrong Expansion Initiatives: In March, GigaCloud introduced a marketplace partnership with Otto Group, a leading European e-commerce and retail company. Through this collaboration, GigaCloud Technology will help onboard selected sellers, including well-known furniture brands and suppliers, onto Otto’s established European marketplace platform. The initiative is expected to boost GigaCloud Technology’s platform activity and drive higher gross merchandise volume through increased seller participation. Moreover, it strengthens the company’s network effects and strategic partnerships, which should support long-term revenue growth and scalability.

Earlier in January, GigaCloud Technology completed the $18 million acquisition of New Classic Home Furnishings to enhance its domestic distribution capabilities. The acquisition further supports GCT’s strategy of creating a channel-agnostic marketplace that strengthens links between suppliers and retailers. Integrating New Classic, a wholesaler with a strong physical retail presence, aligns with GigaCloud Technology’s broader objective of diversifying its operations and expanding beyond the e-commerce space.

Compelling Stock Valuation: From a valuation perspective, GigaCloud Technology is still trading cheaper than the Zacks Technology Services industry. GCT’s valuation is favorable compared with fellow industry players Dave (DAVE - Free Report) and Symbotic (SYM - Free Report) as well. GigaCloud Technology has a Value Score of A. Dave and Symbotic have a Value Score of C and D, respectively.

GCT’s P/S F12M vs. Industry, DAVE & SYMImage Source: Zacks Investment Research

Price Performance: Shares of GigaCloud Technology have performed brilliantly over the past year, gaining in triple digits (% wise). Owing to this solid rally, shares of this company, which simplifies logistics for big and bulky merchandise, have easily outperformed its industry as well as Dave and Symbotic.

1-Year Price Comparison<Image Source: Zacks Investment Research

Final Thoughts: Buy GCT Stock NowThe company’s strong, debt-free balance sheet, the unique business model, expansion efforts and attractive valuation are its major tailwinds. GCT’s impressive earnings history and positive estimate revisions add to its appeal. Given the positives surrounding the company, we believe that investors should add this Zacks Rank #2 (Buy) undervalued stock to their portfolios for healthy returns. The company’s current Zacks Rank supports our stance.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. 

GCT Semiconductor NYSE: GCTS reported higher first-quarter revenue and said its 5G chipset commercialization efforts continued to gain traction, with management pointing to increased shipments, broader customer engagement and progress across fixed wireless access, Internet of Things and non-terrestrial network markets.

Chief Executive Officer John Schlaefer said on the company’s earnings call that GCT delivered 3,000 5G chipsets in the first quarter of 2026, up 58% sequentially from the fourth quarter. He described the volume as still modest relative to the long-term opportunity but said it reflected customers moving through late-stage testing and into initial deployments.

Get GCT Semiconductor alerts:

“Customer confidence in the performance, reliability, and integration of our 5G chipset is building, and we expect 5G chipset shipments to continue trending upward as customers advance their programs,” Schlaefer said.

Revenue Rises on Product and Service Growth Chief Financial Officer Edmond Cheng said first-quarter net revenue rose to $1.9 million from $0.5 million in the same period a year earlier, an increase of $1.4 million, or 287%. The increase included $0.4 million of higher product sales and $1 million of higher service revenue.

Cheng said product sales growth was driven by both 4G and 5G products, while the increase in service revenue was tied to 5G operations. That was partially offset by lower LTE service revenue as GCT shifts its portfolio toward 5G.

Cost of net revenue increased to $1 million from $0.4 million a year earlier, reflecting higher costs from increased unit volume. Gross margin improved to 49% from 18% in the prior-year period, which Cheng attributed largely to revenue mix, including higher-margin service offerings and a greater share of 5G and product sales.

Net revenue: $1.9 million, up from $0.5 million a year earlier Gross margin: 49%, up from 18% a year earlier 5G chipset shipments: 3,000 units, up 58% sequentially Cash and cash equivalents: $7.2 million at quarter-end Management Says Service Revenue Boosted Margin During the question-and-answer session, Schlaefer said service revenue represented a larger portion of quarterly sales in the first quarter, but he emphasized that GCT’s growth strategy is centered on chipset sales rather than services.

“As the chipset sales increase, the chipset sales and product revenue will far outpace that service revenue,” Schlaefer said. “That is our growth. We’re not in the service business.”

Asked about the sustainability of the 49% gross margin, Schlaefer said the quarter’s margin was higher than the company would expect once product revenue dominates the mix. He said GCT continues to expect product-related gross margins to begin around 35% and grow into the low 40% range over time. The company also said gross margin could normalize to the high-30% to low-40% range as chipset sales become more significant.

In response to a question from Lisa Thompson of Zacks Investment Research, management said the first quarter included licensing revenue that would be considered one-time recognition. Future service revenue will depend on contract milestones, and Schlaefer said it is difficult to predict timing in advance.

Satellite Communications Agreement Expands 5G Opportunity Schlaefer highlighted an expanded engagement with what he described as one of the world’s largest satellite communication providers. Under a reference platform agreement, GCT will provide a reference design based on its 4G and 5G chipsets to help accelerate development of the partner’s next-generation user equipment.

The platform is intended to support high-bandwidth and high-speed communications across satellite and terrestrial networks. Schlaefer said the agreement reinforces GCT’s role in enabling connectivity across terrestrial and non-terrestrial networks and creates a “multi-phase opportunity” for adoption as next-generation user equipment platforms are introduced.

Initial 5G chipset shipments to that partner remain on track to begin in the second half of 2026, according to Schlaefer.

Customer Base Broadens as Commercial Ramp Continues Schlaefer said GCT is supporting programs across fixed wireless access, IoT and non-terrestrial network verticals, with customers moving through integration, certification and deployment planning. He said engagements are increasingly extending beyond traditional licensing into platform-level collaboration.

In the Q&A session, Schlaefer said product revenue in the quarter came from at least five customers and potentially as many as seven, noting that some sales move through distribution and may involve multiple end customers. He said early product revenue can be “bursty,” with one customer contributing more in a given quarter before another customer picks up later, but he expects a broader spread of revenue across customers over time.

Expenses and Liquidity Research and development expenses declined to $3.2 million from $4.1 million a year earlier, a decrease of $0.9 million, or 23%. Cheng said the decrease was driven by a $0.5 million reduction in project-specific intellectual property expenses and a $0.4 million reduction in professional services tied to completion of a 5G chipset design last year.

Sales and marketing expenses were relatively steady at $1.2 million, compared with $1.1 million a year earlier. General and administrative expenses were also relatively flat, rising to $2.7 million from $2.6 million.

GCT ended the quarter with $7.2 million in cash and cash equivalents, $2.4 million in net accounts receivable and $1.6 million in net inventory. Cheng said the company has access to an at-the-market equity program of up to $75 million and remaining capacity under its $200 million shelf registration statement.

Management said operating expenses are expected to rise in the second half of the year as R&D spending increases to support the product roadmap. The company said quarterly operating expenses are expected to run at about $8 million beginning in the third quarter.

Schlaefer said GCT remains focused on strengthening its supply chain and operational infrastructure to support higher 5G chipset volumes. He said the company expects sequential growth in 5G chipset shipments as commercialization scales through 2026, while noting that deployment timing can vary as customers finalize rollout plans.

About GCT Semiconductor NYSE: GCTSGCT Semiconductor Holding, Inc, operates as a fabless semiconductor company, designs, develops, and markets integrated circuits for the wireless semiconductor industry. The company provides RF and modem chipsets based on 4G LTE technology, including 4G LTE, 4.5G LTE Advanced, and 4.75G LTE Advanced-Pro. It also develops and sells cellular IoT chipsets for low-speed mobile networks such as eMTC/NB-IOT/Sigfox, and other network protocols; and 5G solutions. Its products and solutions are used in smartphones, tablets, hotspots, CPEs, USB dongles, routers, and M2M applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in GCT Semiconductor Right Now?Before you consider GCT Semiconductor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GCT Semiconductor wasn't on the list.

While GCT Semiconductor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

GCT's EPS beat, 32% revenues jump and buybacks help it gain an edge over NABL. GCT's valuation and price performance are superior as well.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Let's take a look at what these Wall Street heavyweights have to say about GigaCloud Technology Inc. (GCT - Free Report) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.

GigaCloud Technology Inc. currently has an average brokerage recommendation (ABR) of 1.80, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by five brokerage firms. An ABR of 1.80 approximates between Strong Buy and Buy.

Of the five recommendations that derive the current ABR, three are Strong Buy, representing 60% of all recommendations.

Brokerage Recommendation Trends for GCT

Check price target & stock forecast for GigaCloud Technology Inc. here>>>

The ABR suggests buying GigaCloud Technology Inc., but making an investment decision solely on the basis of this information might not be a good idea. According to several studies, brokerage recommendations have little to no success guiding investors to choose stocks with the most potential for price appreciation.

Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every "Strong Sell" recommendation, brokerage firms assign five "Strong Buy" recommendations.

This means that the interests of these institutions are not always aligned with those of retail investors, giving little insight into the direction of a stock's future price movement. It would therefore be best to use this information to validate your own analysis or a tool that has proven to be highly effective at predicting stock price movements.

With an impressive externally audited track record, our proprietary stock rating tool, the Zacks Rank, which classifies stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), is a reliable indicator of a stock's near-term price performance. So, validating the Zacks Rank with ABR could go a long way in making a profitable investment decision.

ABR Should Not Be Confused With Zacks RankAlthough both Zacks Rank and ABR are displayed in a range of 1--5, they are different measures altogether.

Broker recommendations are the sole basis for calculating the ABR, which is typically displayed in decimals (such as 1.28). The Zacks Rank, on the other hand, is a quantitative model designed to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.

It has been and continues to be the case that analysts employed by brokerage firms are overly optimistic with their recommendations. Because of their employers' vested interests, these analysts issue more favorable ratings than their research would support, misguiding investors far more often than helping them.

In contrast, the Zacks Rank is driven by earnings estimate revisions. And near-term stock price movements are strongly correlated with trends in earnings estimate revisions, according to empirical research.

In addition, the different Zacks Rank grades are applied proportionately to all stocks for which brokerage analysts provide current-year earnings estimates. In other words, this tool always maintains a balance among its five ranks.

There is also a key difference between the ABR and Zacks Rank when it comes to freshness. When you look at the ABR, it may not be up-to-date. Nonetheless, since brokerage analysts constantly revise their earnings estimates to reflect changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in predicting future stock prices.

Is GCT Worth Investing In?In terms of earnings estimate revisions for GigaCloud Technology Inc., the Zacks Consensus Estimate for the current year has increased 4.3% over the past month to $4.28.

Analysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.

The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for GigaCloud Technology Inc. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Therefore, the Buy-equivalent ABR for GigaCloud Technology Inc may serve as a useful guide for investors.

May 28, 2026 07:00 ET  | Source: GigaCloud Technology

EL MONTE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce technology solutions for large parcel merchandise, today announced Erica Wei, its Chief Financial Officer, and Iman Schrock, its President, will present at Baird’s 2026 Global Consumer, Technology & Services Conference in New York City on Thursday, June 4, 2026, at 10:50 a.m. ET/7:50 a.m. PT.

GigaCloud also will conduct one-on-one meetings with investors throughout the day. To schedule a meeting, please contact your Baird representative, or PondelWilkinson at [email protected].

About GigaCloud Technology Inc

GigaCloud Technology Inc is a pioneer of global end-to-end B2B ecommerce technology solutions for large parcel merchandise. The Company’s B2B ecommerce platform, which it refers to as the “GigaCloud Marketplace,” integrates everything from discovery, payments and logistics tools into one easy-to-use platform. The Company’s global marketplace seamlessly connects manufacturers, primarily in Asia, with resellers, primarily in the U.S., Asia and Europe, to execute cross-border transactions with confidence, speed and efficiency. The Company offers a truly comprehensive solution that transports products from the manufacturer’s warehouse to the end customer’s doorstep, all at one fixed price. The Company first launched its marketplace in January 2019 by focusing on the global furniture market and has since expanded into additional categories such as home appliances and fitness equipment. For more information, please visit the Company’s website: https://investors.gigacloudtech.com/.

For investor and media inquiries, please contact:

GigaCloud Technology Inc
Investor Relations - [email protected]

PondelWilkinson Inc.
Todd Kehrli (Investors) – [email protected]
Laurie Berman (Investors) – [email protected]
George Medici (Media) – [email protected]

SAN DIEGO, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Sapu Nano and Oncotelic Therapeutics (OTCQB:OTLC) today announced the expansion of its Phase 1b clinical development program for Sapu003 (Everolimus for Injection) and the appointment of Global Clinical Trials (GCT) as the lead contract research organization supporting international execution of Study SP-03-B101.

The announcement follows recent regulatory approvals supporting the study expansion and CRO transition and represents an important milestone in the evolution of the Sapu003 clinical program from its initial Australian clinical footprint toward a broader multinational clinical program.

GCT was selected following a competitive evaluation process that assessed international oncology expertise, regulatory capabilities, operational execution, clinical quality systems, and global logistics infrastructure. Following its appointment, GCT successfully completed key regulatory submissions ahead of schedule and has initiated clinical operations, regulatory coordination, site activation activities, investigational product logistics, and study management functions.

The appointment supports the expansion of the SP-03-B101 study beyond Australia into Europe and represents an important step in establishing the clinical, operational, and regulatory infrastructure necessary to support future multinational Phase 3 development. By building an international clinical network early in development, Sapu Nano aims to position Sapu003 for efficient advancement into global registrational studies following successful completion of ongoing clinical evaluation.

SP-03-B101 is an open-label Phase 1b dose-escalation study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of Sapu003 in patients with advanced mTOR-sensitive solid tumors.

"Sapu003 has progressed from concept through formulation development, manufacturing, regulatory approval, and clinical evaluation in a remarkably short period of time," said Dr. Vuong Trieu, Chief Executive Officer. "The expansion of the program beyond Australia and the appointment of GCT provide the international infrastructure necessary to support continued clinical development. We believe these milestones position Sapu003 for broader global evaluation and future registrational studies while expanding access for patients with advanced cancers."

Sapu003 is a proprietary intravenous formulation of everolimus developed using Sapu Nano's Deciparticle™ platform technology. The program is designed to address limitations associated with oral everolimus administration, including variable absorption, food effects, and first-pass metabolism, while providing more predictable systemic drug exposure through intravenous delivery.

The Company expects the expanded international footprint and integrated clinical operations platform established through GCT to support continued enrollment, future site expansion, and long-term global development objectives for the Sapu003 program.About Deciparticle™

Deciparticle™ is Oncotelic’s proprietary nanomedicine platform designed to formulate highly water-insoluble therapeutics into ultra-small nanoparticles for intravenous administration. The platform utilizes amphiphilic polymer architectures intended to improve aqueous compatibility, stability, manufacturability, and translational flexibility across multiple therapeutic classes.

About Sapu Nano

Sapu Nano is a biotechnology company developing next-generation nanomedicine platforms to improve drug delivery, enhance therapeutic index, and unlock new clinical potential for established and novel therapeutics, with a primary focus in oncology. For more information, visit www.sapunano.com.

About Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of oncology and immunotherapy products. The Company's mission is to address high-unmet-need cancers and rare pediatric indications with innovative, late-stage therapeutic candidates.

In addition to its directly owned and developed drug pipeline, Oncotelic benefits from a robust portfolio of inventions created by its CEO, Dr. Vuong Trieu, who has filed over 500 patent applications and holds 75 issued patents. The Company also leverages its proprietary AI-enabled PDAOAI platform, which supports research, biomarker discovery, and regulatory processes through advanced data analysis and knowledge integration.

Beyond its internal programs, Oncotelic licenses and co-develops select drug candidates through strategic partnerships and joint ventures. The Company currently owns a 45% interest in GMP Bio, a joint venture advancing a complementary pipeline of therapeutic candidates that further strengthens Oncotelic's position in oncology and rare disease therapeutics.

For more information, please visit: www.oncotelic.com

Oncotelic Cautionary Note on Forward Looking Statements

This press release contains forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements in this release other than statements of historical fact are forward looking and are based on current expectations, estimates, and projections about our business and future plans. In some cases, you can identify forward looking statements by terms such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "project," "forecast," "potential," "continue," and similar expressions (including the negative of such terms).

Forward looking statements in this release include, without limitation: our plans, timelines, and priorities for the OT 101 program in PDAC and other indications; potential biomarker driven development strategies; the advancement, scope, timing, and results of current or future preclinical and clinical studies; regulatory interactions and potential approvals; development or commercialization of any product candidates within the Oncotelic/GMP Bio/Sapu ecosystem; the utility of our PDAOAI platform; future financings, strategic transactions, and/or public offerings involving our joint ventures or affiliates; and other statements that are not historical facts. Actual results may differ materially from those indicated by such forward looking statements as a result of various important factors, including, but not limited to: the inherent uncertainties of drug discovery and development; our ability to enroll patients and complete studies on expected timelines; whether preclinical or early clinical findings (including biomarker associations) will be replicated in larger, controlled trials; regulatory developments in the United States and other jurisdictions; competitive developments; our ability to obtain or maintain intellectual property protection; our liquidity and access to capital; the performance of collaborators, suppliers, and manufacturers; and other risks described in our filings with the Securities and Exchange Commission (SEC), including the "Risk Factors" section of our most recent Form 10 K and subsequent periodic reports.

Forward looking statements speak only as of the date of this press release, and we undertake no obligation to update or revise such statements, whether as a result of new information, future events, or otherwise, except as required by law.

Investor & Media Contact
Oncotelic Therapeutics, Inc.
Investor Relations
[email protected]

Corporate Communications

IBN
Austin, Texas
www.InvestorBrandNetwork.com
512.354.7000 Office
[email protected]

I reiterate GigaCloud Technology as a Buy with a $56 price target, implying 76% upside from the current price of $31. My main growth drivers are Europe, the 3P/SFR marketplace mix, New Classic integration, category expansion, and buybacks. In my model, I estimate these drivers can push 2027 revenue toward $1.89Bn and EPS toward $5.05.

GigaCloud Technology is recognized as a 'World Growth Leader of 2026' and delivers robust growth despite headwinds in the U.S. furniture market. GCT posted Q1 2026 revenue of $359.49M (+32% YoY), gross profit up 35%, and net income up 41%, significantly beating EPS expectations. The company's diversified global network and Supplier Fulfilled Retailing® model enable resilience and expansion beyond U.S. market weakness.